Vicki L. Goodman's Insider Trades & SAST Disclosures
Vicki L. Goodman's most recent trade in Mural Oncology plc was a trade of 65,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Vicki L. Goodman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mural Oncology plc | Vicki L. Goodman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 65,000 | 65,000 | - | - | Stock Option (right to buy) | |
| Mural Oncology plc | Vicki L. Goodman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 35,000 | 89,763 | - | 0 | Ordinary Shares | |
| Mural Oncology plc | Vicki L. Goodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 3.89 per share. | 24 Feb 2025 | 13,186 | 54,763 | - | 3.9 | 51,294 | Ordinary Shares |
| Mural Oncology plc | Vicki L. Goodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 3.33 per share. | 07 Nov 2024 | 5,069 | 67,949 | - | 3.3 | 16,880 | Ordinary Shares |
| Mural Oncology plc | Vicki L. Goodman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 135,604 | 135,604 | - | - | Stock Option (right to buy) | |
| Mural Oncology plc | Vicki L. Goodman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 73,018 | 73,018 | - | 0 | Ordinary Shares | |
| Exelixis Inc | Vicki L. Goodman | EVP, Prod Dev & Med Aff &CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 82,566 | 307,654 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Vicki L. Goodman | EVP, Prod Dev & Med Aff &CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.08 per share. | 15 Feb 2023 | 17,299 | 225,088 (0%) | 0% | 18.1 | 312,766 | Common Stock |
| Exelixis Inc | Vicki L. Goodman | EVP, Prod Dev & Med Aff &CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 250,000 | 250,000 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Vicki L. Goodman | EVP, Prod Dev & Med Aff &CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.18 per share. | 04 Jan 2022 | 7,613 | 242,387 (0%) | 0% | 19.2 | 146,017 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges